![Global hereditary angioedema treatment market](https://res.cloudinary.com/devmoveo/image/upload/v1707308623/skyquest/report/phpzcPpZn.jpg)
Report ID: SQMIG35J2031
Report ID:
SQMIG35J2031 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
141 |
Figures:
77
North America dominated the global hereditary angioedema therapy market in 2021 and is expected to continue to do so during the forecast period. The high prevalence of hereditary angioedema, substantially better reported disease ratios, high healthcare expenditure, and availability of speciality HAE products are the primary drivers for the growth of the North American hereditary angioedema treatment market.
Due to increased patient awareness, Asia-Pacific is expected to dominate the global market. The rest of the world is expected to be a highly profitable in the market during the forecast period, owing to factors such as an increase in the number of reported cases of hereditary angioedema in recent times, increased awareness of rare diseases in developing countries, and the introduction of novel therapies.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONHereditary Angioedema Treatment Market size was valued at USD 2.65 billion in 2019 and is poised to grow from USD 2.72 billion in 2023 to USD 10.39 billion by 2031, growing at a CAGR of 2.56% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2031